Quantifying the World's Clinical Trial Efficacy, Tolerability, and Safety Information to Enable Good Drug Development Decisions

Central Nervous System Diseases

QS scientists have worked on many projects across indications in the CNS disease area. The following is a list of indications and level of our experience in each indication:

Extensive experience (>10 projects): Alzheimer’s/Dementia, schizophrenia, epilepsy, anesthesia
Great experience (5-10 projects): Parkinson’s, depression
Good experience (3-5 projects): general anxiety disorder, multiple sclerosis
Some experience (<3 projects): sleep disorders

We have developed a Schizophrenia Clinical Outcomes Database to help facilitate model-based meta-analysis in this disease area. We have also developed an Alzheimer’s database.